1.Economic Burden and Epidemiology of Pneumonia in Korean Adults Aged over 50 Years.
Kwang Ha YOO ; Chul Gyu YOO ; Se Kyu KIM ; Ji Ye JUNG ; Myung Goo LEE ; Soo Taek UH ; Tae Sun SHIM ; Kyeongman JEON ; Jae Jeong SHIM ; Heung Bum LEE ; Chi Ryang CHUNG ; Kyung Woo KANG ; Ki Suck JUNG
Journal of Korean Medical Science 2013;28(6):888-895
This study was performed to estimate the direct medical costs and epidemiology of pneumonia in adults of Korea. We conducted a multi-center, retrospective, observational study and collected data targeting for community-acquired pneumonia patients ( > or = 50 yr) from 11 hospitals. Costs attributable to the treatment of pneumonia were estimated by reviewing resource utilization and epidemiology data (distribution of pathogen, hospital length of stay, overall outcome) were also collected. A total 693 patients were included; average 70.1 ( +/- 10.5) aged, 57.3% male and average 1.16 CURB-65 (confusion, blood urea nitrogen, respiratory rate, blood pressure, age > 65 yr) scored. The pathogen was identified in the 32.9% (228 patients); Streptococcus pneumoniae accounted for 22.4% (51 patients) of identified pathogens. The hospital mortality was 3.2% (especially, for S. pneumoniae was 5.9%) and average length of stay was 9 days. The mean total cost for the treatment of pneumonia was US dollar (USD) 1,782 (SD: USD 1,501). Compared to the cost of all caused pneumonia, that of pneumococcal pneumonia was higher, USD 2,049 ( +/- USD 1,919), but not statistically significant. Charge of hospitalization accounted the greatest part of total medical costs. The economic burden of pneumonia was high in Korea, and the prevention of pneumonia should be considered as effective strategy.
Aged
;
Aged, 80 and over
;
Asian Continental Ancestry Group
;
Community-Acquired Infections/economics/*epidemiology/mortality
;
Female
;
*Health Care Costs
;
Hospital Mortality
;
Hospitalization
;
Humans
;
Length of Stay
;
Male
;
Middle Aged
;
Pneumonia/economics/*epidemiology/microbiology
;
Pneumonia, Pneumococcal/economics/epidemiology/microbiology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Severity of Illness Index
;
Streptococcus pneumoniae/isolation & purification
2.Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases.
Jung Yeon LEE ; Chul Gyu YOO ; Hyo Jin KIM ; Ki Suck JUNG ; Kwang Ha YOO
The Korean Journal of Internal Medicine 2014;29(6):764-773
BACKGROUND/AIMS: This study was conducted to assess the disease burden of pneumonia according to age and presence of underlying diseases in patients admitted with community-acquired pneumonia (CAP). METHODS: We performed a retrospective, observational study and collected data targeting patients with CAP (> or = 50 years) from 11 hospitals. Disease burden was defined as total per-capita medical fee, severity (CURB-65), hospital length of stay (LOS), and mortality. RESULTS: Of the 693 enrolled subjects, elderly subjects (age, > or = 65 years) had a higher mean CURB-65 score (1.56 vs. 0.25; p < 0.01) and higher mortality than nonelderly subjects (4.4% [n = 21] vs. 0.5% [n = 1]; p = 0.00). In addition, the total cost of pneumonia treatment was higher in elderly patients compared to in nonelderly patients (KRW 2,088,190 vs. US $1,701,386; p < 0.01). Those with an underlying disease had a higher CURB-65 score (1.26 vs. 0.68; p < 0.01), were much older (mean age, 71.24 years vs. 64.24 years; p < 0.01), and had a higher mortality rate than those without an underlying disease (3.5% [n = 20] vs. 1.7% [n = 2]; p = 0.56). Total per-capita medical fees were higher (KRW 2,074,520 vs. US $1,440,471; p < 0.01) and hospital LOS was longer (mean, 8.38 days vs. 6.42 days; p < 0.01) in patients with underlying diseases compared to those without. CONCLUSIONS: Due to the relatively high disease burden in Korea, particularly in the elderly and in those with an underlying disease, closer and more careful observation is needed to improve the outcomes of patients with CAP.
Age Distribution
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Community-Acquired Infections/diagnosis/economics/*epidemiology/mortality/therapy
;
Comorbidity
;
Costs and Cost Analysis
;
Female
;
Health Care Costs
;
Hospitalization
;
Humans
;
Length of Stay
;
Male
;
Middle Aged
;
Pneumonia/diagnosis/economics/*epidemiology/mortality/therapy
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Assessment
;
Risk Factors
;
Severity of Illness Index
;
Time Factors